Cure8 research brief
Circulating glycoprotein signals may help explain how systemic inflammation in IBD interacts with metabolic liver disease (MASLD). If validated, they could improve risk stratification for liver complications beyond current non‑invasive tests.
Clinicians and researchers working at the intersection of IBD and liver disease, hepatology and gastroenterology investigators, and patients with IBD who have metabolic risk factors or suspected fatty liver.
This abstract reports a study that measured plasma Glyc-A, Glyc-B and Glyc-F by NMR in people with IBD, with and without MASLD, and matched controls. Glycoprotein concentrations increased from controls to IBD and were highest when IBD and MASLD coexisted; Glyc-B and Glyc-F remained associated with MASLD after adjustment for metabolic variables.
The authors emphasise these findings are biologically interesting but not ready for clinical use.
The signals are composite and influenced by acute-phase proteins, systemic inflammation, adiposity, insulin resistance, dyslipidaemia and liver injury; further work is needed to link them to specific liver outcomes (especially fibrosis) and to show added value beyond existing non-invasive tests.
The source is an abstract in Revista espanola de enfermedades digestivas; the authors caution that glycoprotein NMR signals are composite markers influenced by multiple processes and that current evidence supports biological plausibility but not routine clinical use.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
If you have overweight or obesity, this study suggests measurable blood proteins linked to inflammation may be associated with higher future risk of ulcerative colitis. Identifying such markers could help research on...
IBD increases risk of osteoporosis; identifying blood proteins that predict later bone loss could help flag higher-risk patients and reveal biological links between gut inflammation and bone health.
The study identifies colonic gene-expression programs that correlate with treatment failure, higher surgery rates, and perianal disease in Crohn’s — findings that could guide future prognostic tests and targeted...
